Propanc Biopharma, Inc. (PPCB)
Nasdaq: PPCB · CIK 0001517681 · United States
Every official Propanc Biopharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PPCB filings
Propanc Biopharma, Inc. documents
- Propanc Biopharma, Inc. 10-K 2026PPCB 10-K 2026: annual report for fiscal 2026
- Propanc Biopharma, Inc. 10-K 2025PPCB 10-K 2025: annual report for fiscal 2025
- Propanc Biopharma, Inc. 10-K 2024PPCB 10-K 2024: annual report for fiscal 2024
- Propanc Biopharma, Inc. 10-K 2023PPCB 10-K 2023: annual report for fiscal 2023
- Propanc Biopharma, Inc. 10-K 2022PPCB 10-K 2022: annual report for fiscal 2022
- Propanc Biopharma, Inc. 10-Q 2026PPCB 10-Q 2026: quarterly report for fiscal 2026
- Propanc Biopharma, Inc. 10-Q 2025PPCB 10-Q 2025: quarterly report for fiscal 2025
- Propanc Biopharma, Inc. 10-Q 2024PPCB 10-Q 2024: quarterly report for fiscal 2024
- Propanc Biopharma, Inc. 10-Q 2023PPCB 10-Q 2023: quarterly report for fiscal 2023
- Propanc Biopharma, Inc. 10-Q 2022PPCB 10-Q 2022: quarterly report for fiscal 2022
- Propanc Biopharma, Inc. 8-K 2026PPCB 8-K 2026: current report for fiscal 2026
- Propanc Biopharma, Inc. 8-K 2025PPCB 8-K 2025: current report for fiscal 2025
- Propanc Biopharma, Inc. 8-K 2024PPCB 8-K 2024: current report for fiscal 2024
- Propanc Biopharma, Inc. 8-K 2023PPCB 8-K 2023: current report for fiscal 2023
- Propanc Biopharma, Inc. 8-K 2022PPCB 8-K 2022: current report for fiscal 2022
- Propanc Biopharma, Inc. DEF 14A 2026PPCB DEF 14A 2026: proxy statement for fiscal 2026
- Propanc Biopharma, Inc. DEF 14A 2025PPCB DEF 14A 2025: proxy statement for fiscal 2025
- Propanc Biopharma, Inc. DEF 14A 2024PPCB DEF 14A 2024: proxy statement for fiscal 2024
- Propanc Biopharma, Inc. DEF 14A 2023PPCB DEF 14A 2023: proxy statement for fiscal 2023
- Propanc Biopharma, Inc. DEF 14A 2022PPCB DEF 14A 2022: proxy statement for fiscal 2022
- Propanc Biopharma, Inc. Form 4 2026PPCB Form 4 2026: insider trading filing for fiscal 2026
- Propanc Biopharma, Inc. Form 4 2025PPCB Form 4 2025: insider trading filing for fiscal 2025
- Propanc Biopharma, Inc. Form 4 2024PPCB Form 4 2024: insider trading filing for fiscal 2024
- Propanc Biopharma, Inc. Form 4 2023PPCB Form 4 2023: insider trading filing for fiscal 2023
- Propanc Biopharma, Inc. Form 4 2022PPCB Form 4 2022: insider trading filing for fiscal 2022
- Propanc Biopharma, Inc. S-1 2026PPCB S-1 2026: registration statement for fiscal 2026
- Propanc Biopharma, Inc. S-1 2025PPCB S-1 2025: registration statement for fiscal 2025
- Propanc Biopharma, Inc. S-1 2024PPCB S-1 2024: registration statement for fiscal 2024
- Propanc Biopharma, Inc. S-1 2023PPCB S-1 2023: registration statement for fiscal 2023
- Propanc Biopharma, Inc. S-1 2022PPCB S-1 2022: registration statement for fiscal 2022
- Propanc Biopharma, Inc. 13F 2026PPCB 13F 2026: institutional holdings for fiscal 2026
- Propanc Biopharma, Inc. 13F 2025PPCB 13F 2025: institutional holdings for fiscal 2025
- Propanc Biopharma, Inc. 13F 2024PPCB 13F 2024: institutional holdings for fiscal 2024
- Propanc Biopharma, Inc. 13F 2023PPCB 13F 2023: institutional holdings for fiscal 2023
- Propanc Biopharma, Inc. 13F 2022PPCB 13F 2022: institutional holdings for fiscal 2022
More companies